Letter to the Editor June 15, 2017

A Case of Fluoxetine-Induced Lower Extremity Ecchymosis

Buğra Çetin, MD; Mine Ergelen, MD

Prim Care Companion CNS Disord 2017;19(3):16l02061

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

To the Editor: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) mainly prescribed in the treatment of depression, anxiety disorders, bulimia nervosa, and premenstrual syndrome. Although SSRIs have been reported to potentially be associated with an increased risk of bleeding, fluoxetine-induced ecchymosis is rare, with few cases in the current literature. We report the case of a female patient who manifested lower-extremity ecchymosis related to fluoxetine use.

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40.00

Members enjoy free PDF downloads on all articles. Join today